024 Pharma, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/17 Q1 2017 – amended

ended 03/31/17 Q1

ended 12/31/16 FY 2016

ended 06/30/16 Q2

ended 09/30/16 Q3

Prospectuses and Registrations Filter

Suspension of duty to report

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Ownership Filter

Lg Capital Funding, LLC

Tangiers Investment Group, LLC

Macallan Partners LLC

Mahoney Jerome R

YA Global Investments

News Filter

Change of Control

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Material Definitive Agreement, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Material Disclosure, Financial Statements or Exhibits

Material Modification to Rights of Security Holders, Change in Certifying Accountant, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies Filter

Preliminary info

Other Filter

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC